Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

An Appraisal of Current Guidelines for Managing Malignancy in Pancreatic Intraductal Papillary Mucinous Neoplasm.

Takakura K, Torisu Y, Kinoshita Y, Tomita Y, Nakano M, Oikawa T, Tsukinaga S, Sumiyama K, Eibl G, Saruta M.

JOP. 2018 Jul;19(4):178-182. Epub 2018 Jul 30.

2.

Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy.

Tsukinaga S, Kajihara M, Takakura K, Ito Z, Kanai T, Saito K, Takami S, Kobayashi H, Matsumoto Y, Odahara S, Uchiyama K, Arakawa H, Okamoto M, Sugiyama H, Sumiyama K, Ohkusa T, Koido S.

World J Gastroenterol. 2015 Oct 21;21(39):11168-78. doi: 10.3748/wjg.v21.i39.11168.

3.

Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy.

Koido S, Kan S, Yoshida K, Yoshizaki S, Takakura K, Namiki Y, Tsukinaga S, Odahara S, Kajihara M, Okamoto M, Ito M, Yusa S, Gong J, Sugiyama H, Ohkusa T, Homma S, Tajiri H.

Anticancer Res. 2014 Nov;34(11):6353-61.

PMID:
25368235
4.

Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer.

Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, Tsukinaga S, Odahara S, Koyama S, Imazu H, Uchiyama K, Kajihara M, Arakawa H, Misawa T, Toyama Y, Yanagisawa S, Ikegami M, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Ishidao T, Yusa S, Shimodaira S, Gong J, Sugiyama H, Ohkusa T, Tajiri H.

Clin Cancer Res. 2014 Aug 15;20(16):4228-39. doi: 10.1158/1078-0432.CCR-14-0314. Epub 2014 Jul 23.

5.

Long-term management of gemcitabine in a patient with advanced pancreatic cancer undergoing haemodialysis.

Takakura K, Koido S, Takahara A, Odahara S, Mitobe J, Matsudaira H, Tsukinaga S, Yukawa T, Matsumoto K, Nagatsuma K, Uchiyama K, Kajihara M, Ohkusa T, Tajiri H.

J Chemother. 2014 Dec;26(6):369-72. doi: 10.1179/1973947813Y.0000000150. Epub 2013 Dec 6.

PMID:
24621160
6.

Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.

Koido S, Ohkusa T, Kajiura T, Shinozaki J, Suzuki M, Saito K, Takakura K, Tsukinaga S, Odahara S, Yukawa T, Mitobe J, Kajihara M, Uchiyama K, Arakawa H, Tajiri H.

PLoS One. 2014 Jan 29;9(1):e86702. doi: 10.1371/journal.pone.0086702. eCollection 2014.

7.

Clinical significance of serum procalcitonin in patients with ulcerative colitis.

Koido S, Ohkusa T, Takakura K, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Kajihara M, Uchiyama K, Arakawa H, Tajiri H.

World J Gastroenterol. 2013 Dec 7;19(45):8335-41. doi: 10.3748/wjg.v19.i45.8335.

8.

Edwardsiella tarda superinfection in relapse of ulcerative colitis.

Koido S, Ohkusa T, Kato K, Shimamoto N, Takakura K, Odahara S, Tsukinaga S, Mitobe J, Yukawa T, Kajihara M, Uchiyama K, Arakawa H, Tajiri H.

J Clin Gastroenterol. 2014 Feb;48(2):191-3. doi: 10.1097/01.mcg.0000437809.46982.df. No abstract available.

PMID:
24326755
9.

Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production.

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Kajihara M, Uchiyama K, Arihiro S, Imazu H, Arakawa H, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Hara E, Ohkusa T, Gong J, Tajiri H.

PLoS One. 2013 May 24;8(5):e63498. doi: 10.1371/journal.pone.0063498. Print 2013.

10.

Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes.

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H.

PLoS One. 2013;8(3):e59280. doi: 10.1371/journal.pone.0059280. Epub 2013 Mar 15.

11.

Nested culture method improves detection of Fusobacterium from stool in patients with ulcerative colitis.

Yukawa T, Ohkusa T, Shibuya T, Tsukinaga S, Mitobe J, Takakura K, Takahara A, Odahara S, Matsudaira H, Nagatsuma K, Kitahara T, Kajihara M, Uchiyama K, Arakawa H, Koido S, Tajiri H.

Jpn J Infect Dis. 2013;66(2):109-14.

12.

Current immunotherapeutic approaches in pancreatic cancer.

Koido S, Homma S, Takahara A, Namiki Y, Tsukinaga S, Mitobe J, Odahara S, Yukawa T, Matsudaira H, Nagatsuma K, Uchiyama K, Satoh K, Ito M, Komita H, Arakawa H, Ohkusa T, Gong J, Tajiri H.

Clin Dev Immunol. 2011;2011:267539. doi: 10.1155/2011/267539. Epub 2011 Sep 14. Review.

13.

Diagnostic approach using endosonography guided fine needle aspiration for lymphadenopathy in primary sclerosing cholangitis.

Tsukinaga S, Imazu H, Uchiyama Y, Kakutani H, Kuramoti A, Kato M, Kanazawa K, Kobayashi T, Searashi Y, Tajiri H.

World J Gastroenterol. 2007 Jul 21;13(27):3758-9.

14.

[A case of widespread ileal stenosis caused by metastatic disseminated peritoneal carcinomatosis from lung cancer resected 8 years previously].

Uchiyama K, Nakamura M, Tsukinaga S, Koido S, Yamane T, Fujise K, Yoshimoto K, Ishii T, Ohmura M, Yamaguchi Y, Tajiri H.

Nihon Shokakibyo Gakkai Zasshi. 2007 Mar;104(3):381-7. Japanese.

PMID:
17337875
15.

New generation argon plasma coagulation in flexible endoscopy: ex vivo study and clinical experience.

Sumiyama K, Kaise M, Kato M, Saito S, Goda K, Odagi I, Tamai N, Tsukinaga S, Matsunaga K, Tajiri H.

J Gastroenterol Hepatol. 2006 Jul;21(7):1122-8.

PMID:
16824063
16.

New approach to diagnosing ampullary tumors by magnifying endoscopy combined with a narrow-band imaging system.

Uchiyama Y, Imazu H, Kakutani H, Hino S, Sumiyama K, Kuramochi A, Tsukinaga S, Matsunaga K, Nakayoshi T, Goda K, Saito S, Kaise M, Kawamuara M, Omar S, Tajiri H.

J Gastroenterol. 2006 May;41(5):483-90.

PMID:
16799891

Supplemental Content

Loading ...
Support Center